医学
回顾性队列研究
抗生素耐药性
内科学
队列研究
抗菌剂
流行病学
抗药性
梅德林
队列
年轻人
重症监护医学
疾病
抗生素
儿科
急诊医学
作者
Mohan Bilikallahalli Sannathimmappa,Mohammed Idris Qureshi,Syeda Heyam,Majid Al Lawati,Tasnim Saif Alamri,Qabas Hamood Al-harmali,Vinod Nambiar,Salima Al-Maqbali
出处
期刊:Infection
[Springer Science+Business Media]
日期:2026-09-16
被引量:1
标识
DOI:10.1007/s15010-026-02979-5
摘要
Abstract Background. Vancomycin-resistant enterococci (VRE) are an escalating cause of healthcare-associated infection, yet regional data from the Arabian Peninsula and pragmatic outcome-prediction tools remain scarce. We characterized the epidemiology, resistance patterns and predictors of mortality of enterococcal isolates over six years at a tertiary hospital in Oman. Methods. We analyzed 1,626 non-duplicate Enterococcus isolates (1,018 patients, 2020–2025). Resistance was interpreted as susceptible/intermediate/resistant; VRE was defined by vancomycin resistance or laboratory VRE flag; multidrug resistance (MDR) followed standard criteria. A chart-reviewed VRE cohort (n = 213) provided comorbidity, biomarker and outcome data for univariable and multivariable logistic regression and cross-validated machine-learning models. Results. VRE accounted for 24.3% of isolates and rose from 1.8% (2020) to 47.4% (2025) (trend p < 0.001). E. faecium carried 73.4% of resistance. Linezolid (0.9%) and tigecycline (1.9%) retained activity. In-hospital mortality in the VRE cohort was 31.9%; low serum albumin was the only independent predictor (adjusted OR 0.86 per g/L, p = 0.004). Conclusions. VRE has risen sharply in this setting, concentrated in E. faecium , with preserved last-line susceptibility. Routine admission biomarkers, especially albumin, and machine-learning models offer accessible mortality risk-stratification.
科研通智能强力驱动
Strongly Powered by AbleSci AI